Podcasts about jublia

Here are the links for everything discussed in Episode 32, I'm also including times here so feel free to skip ahead to the topics that interest you. (1:30) Approval of Ongentys for Parkinson's disease (3:45) MenQuadi vaccine approval (5:40) Zejula indication expansion in ovarian cancer (7:35) Jublia added age range approval (9:30) New Dosing approved for Keytruda Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

How one of Canada’s top NHL teams combat some of their most common foot-related issues.

How one of Canada’s top NHL teams combat some of their most common foot-related issues.

Management of Onychomycosis in Canada in 2014 http://www.ncbi.nlm.nih.gov/pubmed/25775640 Drug name: Brand: SA SA Criteria SA Approval period Direction SE Monitoring Ciclopirox 8% Penlac (nail lacquer) No Not covered N/A Nail lacquer: Apply bid to adjacent skin and affected nails daily. Remove with alcohol every 7 days (treat 4 weeks) dermatitis, dry skin, local burning sensation Efinaconazole […] The post Onychomycosis appeared first on Family Pharm Podcast.

If you're one of the 2.4 million Canadians suffering from this uncomfortable condition, new hope has surfaced

If you're one of the 2.4 million Canadians suffering from this uncomfortable condition, new hope has surfaced

In this podcast, Dr. Linda Stein-Gold presents on the use of Jublia for Toenail Onychomycosis. Her lecture was sponsored by Valeant and recorded at the 2014 SDPA Fall Conference in San Diego.

Today in FirstWord: